Benign Prostatic Hyperplasia Surgical Treatment Market to Hit USD 17.19 Billion by 2030 ...
The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow ...
Holmium Laser of the Prostate Double-n Technology promising for benign prostatic hyperplasia
For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...
Rolling Out10 小时
Doctors reveal deadly mistake men make by age 50
Medical experts explain why men must prioritize prostate health screenings and share lifesaving reasons to schedule regular PSA tests and physical exams.
HealthDay on MSN11 天
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...
BioWorld5 天
RNA panel detects and differentiates prostate cancer from benign prostate hyperplasia
Prostate cancer is still one of the main causes of cancer death among men; while prostate-specific antigen (PSA) testing is done for screening, there are recommendations against its use due to its ...
Renal & Urology News12 天
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
Improvement in urinary symptoms with better preservation of ejaculatory function seen with double-n technology. (HealthDay News) — For men with benign prostatic hyperplasia (BPH), transurethral ...